COLGATE-PALMOLIVE COMPANY (CL) FY2024 Annual P&L / Income Statement

COLGATE-PALMOLIVE COMPANY (CL) FY2024 Annual P&L / Income Statement

Income statement for 2024-01-01 through 2024-12-31. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

20,101,000,000 US dollars

Cost of sales

7,940,000,000 US dollars

Gross profit

12,161,000,000 US dollars

Operating costs, including other operating expenses (calculated)

7,893,000,000 US dollars

Operating profit

4,268,000,000 US dollars

Other income (expense), net (calculated)

negative 312,000,000 US dollars

Income before income taxes

3,956,000,000 US dollars

Provision for income taxes

907,000,000 US dollars

Net income including noncontrolling interests

3,049,000,000 US dollars

Oral, Personal and Home Care - UNITED STATES

3,640,000,000 US dollars

Pet Nutrition - UNITED STATES

3,059,000,000 US dollars

Undisclosed (calculated)

13,402,000,000 US dollars

Selling, general and administrative expenses

7,729,000,000 US dollars

Goodwill and intangible assets impairment charges

0 US dollars

Other (income) expense, net

164,000,000 US dollars

Oral, Personal and Home Care - UNITED STATES costs (calculated)

11,530,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Pet Nutrition - UNITED STATES costs (calculated)

3,518,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Reconciling items (calculated)

785,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to COLGATE-PALMOLIVE COMPANY: $2.89 B; to noncontrolling interests: $160.00 M.